Heidelberg Epignostix
Heidelberg
About Heidelberg Epignostix
Heidelberg Epignostix is a pioneering start-up led by a dedicated team of DNA methylation-based tumor categorization experts. Heidelberg Epignostix has revolutionized tumor categorization by using the strength of methylation-based algorithms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.6M
- Funding stage: Seed
- Last round: Seed (Jul 2024)
- Website: epignostix.com
Industries & Categories
Hospital, Medical, Wellness
Social Profiles
Canonical: https://fsome.com/organization/heidelberg-epignostix-70964 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.